Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- We rounded up 23 of the most promising healthcare startups;
- Smaller pharmacy benefit managers reimagining how we pay for drugs are winning out as companies ditch incumbents;
- Here are the lengths digital health dealmakers are going to amid an industry boom.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…
Tomorrow, June 30, is your last day to submit nominations for our annual 30 under 40 list!
Send in your last-minute nominations here. Can't wait to check them all out!
Elektra Health
23 of the most promising healthcare startups of 2021, according to top VCs
- We asked top venture capitalists to name the most promising US healthcare startups so far in 2021.
- VCs were asked to name companies in their portfolios and ones with which they had no financial ties.
- They named startups across healthcare segments, from biotech to digital health and wellness.
A pharmacist is seen counting prescription pills in June, 2019.
Chris Wattie/Reuters
Chris Wattie/Reuters
Companies are ditching massive drug-industry middlemen in favor of smaller competitors reimagining how we pay for drugs
- Drug-industry middlemen called pharmacy benefit managers are in trouble for overcharging customers.
- That's driving business to companies that promise transparency and say they operate differently.
- But breaking in is tough for alternative PBMs that aren't valued as highly by powerful consultants.
The financial-services industry has been hit by employee burnouts as the pandemic leaves them sometimes working longer hours.
Cecilie Arcurs/Getty Images
Digital-health dealmakers are working 18-hour days 7 days a week to keep up with the booming industry
Cecilie Arcurs/Getty Images
- Dealmakers have been working overtime during the digital-health boom.
- Lawyers, bankers, and investors pull all-nighters and work seven days a week to make deals happen.
- Private funding for digital-health companies continues to break records each quarter in 2021.
More stories we're reading:
- Intellia reported that six patients have safely had the DNA in their liver cells edited using the CRISPR gene-editing tool (Stat News)
- How Americans waged war on the scientists trying to save them (Insider)
- San Diego is suing three insurers, alleging they haven't been maintaining accurate provider directories (Healthcare Dive)
- A former CIA officer opens up about his Havana Syndrome: 3 years of headaches, early retirement, and a fight for care (Insider)
- Lydia
Read the original article on Business Insider